Monoclonal Antibodies: Unlocking Cost and Efficiency Gains in Downstream Processing
Kristina Pleitt
Senior Staff Scientist
Thermo Fisher Scientific
- Time:
Analytical developers and downstream scientists are under constant pressure to improve process efficiency while maintaining product quality for monoclonal antibodies (mAbs). Yet, many platform purification processes still leave untapped opportunities for optimization, cost reduction, and simplification.
In this webinar, our speaker will explore a series of practical, chromatography-focused strategies designed to enhance mAb purification performance while reducing cost of goods (COGs). Using real-world examples and process scenarios, attendees will gain insight into:
- Identifying opportunities to simplify traditional mAb purification workflows
- Improving Protein A performance and lifetime to drive cost savings
- Enabling efficient two-step downstream processes through better impurity management
- Addressing difficult HCP and aggregate clearance challenges with advanced polishing strategies
A live Q&A session will follow the presentation, offering you a chance to engage directly with our expert and discuss how these approaches can be applied to your own processes.
Produced with support from:
The post Monoclonal Antibodies: Unlocking Cost and Efficiency Gains in Downstream Processing appeared first on GEN - Genetic Engineering and Biotechnology News.
Apa Reaksi Anda?
Suka
0
Kurang Suka
0
Setuju
0
Tidak Setuju
0
Bagus
0
Berguna
0
Hebat
0

